ArticleAmerican journal of preventive cardiology2026
Lifetime cost-effectiveness of semaglutide for secondary prevention in atherosclerotic cardiovascular disease: A select-based simulation study.
Sai Rahul Ponnana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.